Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury

Clinical trial NCT05524103 · COMPLETED

Trial details

NCT number: NCT05524103
Sponsor: AlaMab Therapeutics (Shanghai) Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Spinal Cord Injury

Start date: 2022-04-15
Primary completion: 2025-02-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.